News

Researchers have closely monitored the evolution of the virus in two chronic patients undergoing combination therapy with the antiviral agent ribavirin and sofosbuvir, which was developed to combat hepatitis C.

Cameroon today launched the RTS,S malaria vaccine into its routine national immunization services, becoming the first country to do so outside the malaria vaccine pilot programme that was carried out in Ghana, Kenya and Malawi.

How, exactly, DMT alters brain function to produce positive effects observed in clinical trials is not yet clear, though a study from scientists at Imperial College London has shed some light.

Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study intended to inform development of a preventive HIV vaccine for people.

Researchers have taken a closer look at how breast cancer develops and have identified an RNA molecule that can suppress cancer formation.

Researchers have exploited mRNA technology to develop a therapy for a rare disease, which has shown promise in mouse models.

Researchers have analyzed the rise of antibiotic resistance over the last 20 years in the UK and Norway, highlighting that antibiotic use is not the only factor in the increase.

The US FDA approved 55 novel drugs in 2023 – the second-highest figure in the last 30 years. This is almost a 50% increase compared to 2022, which saw 37 new approvals.

Researchers have formed a consortium to reduce the global burden of diarrhoeal disease worsened by climate change, starting by mapping areas that are most vulnerable to increased deaths.

A vaccine has shown the potential to prevent the relapse of KRAS-mutated pancreatic and colorectal cancers in a phase I trial.